410 related articles for article (PubMed ID: 13130291)
1. [Congenital disorders of glycosylation].
Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
[TBL] [Abstract][Full Text] [Related]
2. [Molecular diagnosis of congenital disorders of glycosylation].
Vuillaumier-Barrot S
Ann Biol Clin (Paris); 2005; 63(2):135-43. PubMed ID: 15771971
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
4. Congenital disorders of glycosylation: a review.
Grunewald S; Matthijs G; Jaeken J
Pediatr Res; 2002 Nov; 52(5):618-24. PubMed ID: 12409504
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
Barone R; Sturiale L; Garozzo D
Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
[TBL] [Abstract][Full Text] [Related]
7. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
[TBL] [Abstract][Full Text] [Related]
9. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
[TBL] [Abstract][Full Text] [Related]
10. [Congenital disorders of glycosylation: state of the art and Spanish experience].
Vilaseca MA; Artuch R; Briones P
Med Clin (Barc); 2004 May; 122(18):707-16. PubMed ID: 15171833
[TBL] [Abstract][Full Text] [Related]
11. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
12. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.
Cylwik B; Naklicki M; Chrostek L; Gruszewska E
Acta Biochim Pol; 2013; 60(2):151-61. PubMed ID: 23730680
[TBL] [Abstract][Full Text] [Related]
13. Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects.
Leroy JG
Pediatr Res; 2006 Dec; 60(6):643-56. PubMed ID: 17065563
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder.
Wu X; Steet RA; Bohorov O; Bakker J; Newell J; Krieger M; Spaapen L; Kornfeld S; Freeze HH
Nat Med; 2004 May; 10(5):518-23. PubMed ID: 15107842
[TBL] [Abstract][Full Text] [Related]
15. Screening and diagnosis of congenital disorders of glycosylation.
Marklová E; Albahri Z
Clin Chim Acta; 2007 Oct; 385(1-2):6-20. PubMed ID: 17716641
[TBL] [Abstract][Full Text] [Related]
16. Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
Schollen E; Dorland L; de Koning TJ; Van Diggelen OP; Huijmans JG; Marquardt T; Babovic-Vuksanovic D; Patterson M; Imtiaz F; Winchester B; Adamowicz M; Pronicka E; Freeze H; Matthijs G
Hum Mutat; 2000 Sep; 16(3):247-52. PubMed ID: 10980531
[TBL] [Abstract][Full Text] [Related]
17. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups.
Wopereis S; Morava E; Grünewald S; Adamowicz M; Huijben KM; Lefeber DJ; Wevers RA
Glycobiology; 2005 Dec; 15(12):1312-9. PubMed ID: 16037491
[TBL] [Abstract][Full Text] [Related]
18. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
[TBL] [Abstract][Full Text] [Related]
19. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation.
Foulquier F; Ungar D; Reynders E; Zeevaert R; Mills P; García-Silva MT; Briones P; Winchester B; Morelle W; Krieger M; Annaert W; Matthijs G
Hum Mol Genet; 2007 Apr; 16(7):717-30. PubMed ID: 17220172
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
